Cargando…

Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population

OBJECTIVES: Metabolically healthy obese (MHO) phenotype describes an obese state with a favorable metabolic profile. However, the prognosis of this subpopulation remains controversial. We aimed to examine whether MHO phenotype is associated with progression of atherosclerotic activity, reflected as...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Yu Mi, Jung, Chang Hee, Cho, Yun Kyung, Lee, Seung Eun, Lee, Min Jung, Hwang, Jenie Yoonoo, Kim, Eun Hee, Park, Joong-Yeol, Lee, Woo Je, Kim, Hong-Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395191/
https://www.ncbi.nlm.nih.gov/pubmed/28419118
http://dx.doi.org/10.1371/journal.pone.0175762
_version_ 1783229834679287808
author Kang, Yu Mi
Jung, Chang Hee
Cho, Yun Kyung
Lee, Seung Eun
Lee, Min Jung
Hwang, Jenie Yoonoo
Kim, Eun Hee
Park, Joong-Yeol
Lee, Woo Je
Kim, Hong-Kyu
author_facet Kang, Yu Mi
Jung, Chang Hee
Cho, Yun Kyung
Lee, Seung Eun
Lee, Min Jung
Hwang, Jenie Yoonoo
Kim, Eun Hee
Park, Joong-Yeol
Lee, Woo Je
Kim, Hong-Kyu
author_sort Kang, Yu Mi
collection PubMed
description OBJECTIVES: Metabolically healthy obese (MHO) phenotype describes an obese state with a favorable metabolic profile. However, the prognosis of this subpopulation remains controversial. We aimed to examine whether MHO phenotype is associated with progression of atherosclerotic activity, reflected as the changes in coronary artery calcification (CAC) over time. If so, we sought to determine the role of fatty liver disease (FLD), the hallmark of hepatic steatosis, in this progression. METHODS: We enrolled 1,240 asymptomatic subjects who underwent repeated CAC score measurement during routine health examinations. CAC score progression was defined as either incident CAC in a population free of CAC at baseline, or an increase by ≥2.5 units between the baseline and final square root of CAC scores in participants with detectable CAC at baseline. Subjects were stratified by body mass index (cut-off, 25.0 kg/m(2)) and metabolic health state using Adult Treatment Panel-III criteria. FLD was assessed via ultrasonography. RESULTS: Over 2.9 years of follow-up, 25.2% of total subjects exhibited CAC score progression. The MHO phenotype was not significantly associated with CAC score progression (multivariate adjusted-odds ratio [OR], 1.45; 95% confidence interval [CI], 0.93–2.25), as compared to the metabolically healthy non-obese (MHNO) phenotype. However, subgroup analysis indicated that the MHO/FLD phenotype was significantly associated with CAC score progression (multivariate adjusted-OR, 2.37; 95% CI, 1.34–4.16), as compared to the MHNO/no FLD phenotype, whereas the MHO/no FLD phenotype was not (multivariate adjusted OR, 1.25; 95% CI, 0.71–2.24). CONCLUSIONS: Obese individuals with FLD have an increased risk of atherosclerosis progression, despite their healthy metabolic profile. Preventive interventions targeting cardiometabolic risk factors should be considered in such individuals, regardless of the weight status.
format Online
Article
Text
id pubmed-5395191
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-53951912017-05-04 Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population Kang, Yu Mi Jung, Chang Hee Cho, Yun Kyung Lee, Seung Eun Lee, Min Jung Hwang, Jenie Yoonoo Kim, Eun Hee Park, Joong-Yeol Lee, Woo Je Kim, Hong-Kyu PLoS One Research Article OBJECTIVES: Metabolically healthy obese (MHO) phenotype describes an obese state with a favorable metabolic profile. However, the prognosis of this subpopulation remains controversial. We aimed to examine whether MHO phenotype is associated with progression of atherosclerotic activity, reflected as the changes in coronary artery calcification (CAC) over time. If so, we sought to determine the role of fatty liver disease (FLD), the hallmark of hepatic steatosis, in this progression. METHODS: We enrolled 1,240 asymptomatic subjects who underwent repeated CAC score measurement during routine health examinations. CAC score progression was defined as either incident CAC in a population free of CAC at baseline, or an increase by ≥2.5 units between the baseline and final square root of CAC scores in participants with detectable CAC at baseline. Subjects were stratified by body mass index (cut-off, 25.0 kg/m(2)) and metabolic health state using Adult Treatment Panel-III criteria. FLD was assessed via ultrasonography. RESULTS: Over 2.9 years of follow-up, 25.2% of total subjects exhibited CAC score progression. The MHO phenotype was not significantly associated with CAC score progression (multivariate adjusted-odds ratio [OR], 1.45; 95% confidence interval [CI], 0.93–2.25), as compared to the metabolically healthy non-obese (MHNO) phenotype. However, subgroup analysis indicated that the MHO/FLD phenotype was significantly associated with CAC score progression (multivariate adjusted-OR, 2.37; 95% CI, 1.34–4.16), as compared to the MHNO/no FLD phenotype, whereas the MHO/no FLD phenotype was not (multivariate adjusted OR, 1.25; 95% CI, 0.71–2.24). CONCLUSIONS: Obese individuals with FLD have an increased risk of atherosclerosis progression, despite their healthy metabolic profile. Preventive interventions targeting cardiometabolic risk factors should be considered in such individuals, regardless of the weight status. Public Library of Science 2017-04-18 /pmc/articles/PMC5395191/ /pubmed/28419118 http://dx.doi.org/10.1371/journal.pone.0175762 Text en © 2017 Kang et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Kang, Yu Mi
Jung, Chang Hee
Cho, Yun Kyung
Lee, Seung Eun
Lee, Min Jung
Hwang, Jenie Yoonoo
Kim, Eun Hee
Park, Joong-Yeol
Lee, Woo Je
Kim, Hong-Kyu
Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population
title Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population
title_full Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population
title_fullStr Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population
title_full_unstemmed Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population
title_short Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population
title_sort fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395191/
https://www.ncbi.nlm.nih.gov/pubmed/28419118
http://dx.doi.org/10.1371/journal.pone.0175762
work_keys_str_mv AT kangyumi fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation
AT jungchanghee fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation
AT choyunkyung fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation
AT leeseungeun fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation
AT leeminjung fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation
AT hwangjenieyoonoo fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation
AT kimeunhee fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation
AT parkjoongyeol fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation
AT leewooje fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation
AT kimhongkyu fattyliverdiseasedeterminestheprogressionofcoronaryarterycalcificationinametabolicallyhealthyobesepopulation